Innate Pharma SA (IPHA)
2.545
+0.12
(+4.75%)
USD |
NASDAQ |
May 03, 16:00
2.42
-0.13
(-4.93%)
After-Hours: 20:00
Innate Pharma Total Return Level: 2.545 for May 3, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 03, 2024 | 2.545 |
May 02, 2024 | 2.43 |
May 01, 2024 | 2.54 |
April 30, 2024 | 2.31 |
April 29, 2024 | 2.47 |
April 26, 2024 | 2.46 |
April 25, 2024 | 2.40 |
April 24, 2024 | 2.46 |
April 23, 2024 | 2.37 |
April 22, 2024 | 2.425 |
April 19, 2024 | 2.44 |
April 18, 2024 | 2.35 |
April 17, 2024 | 2.41 |
April 16, 2024 | 2.59 |
April 15, 2024 | 2.42 |
April 12, 2024 | 2.48 |
April 11, 2024 | 2.48 |
April 10, 2024 | 2.52 |
April 09, 2024 | 2.60 |
April 08, 2024 | 2.60 |
April 05, 2024 | 2.532 |
April 04, 2024 | 2.50 |
April 03, 2024 | 2.57 |
April 02, 2024 | 2.52 |
April 01, 2024 | 2.68 |
Date | Value |
---|---|
March 28, 2024 | 2.88 |
March 27, 2024 | 2.38 |
March 26, 2024 | 2.44 |
March 25, 2024 | 2.40 |
March 22, 2024 | 2.372 |
March 21, 2024 | 2.410 |
March 20, 2024 | 2.50 |
March 19, 2024 | 2.43 |
March 18, 2024 | 2.39 |
March 15, 2024 | 2.525 |
March 14, 2024 | 2.52 |
March 13, 2024 | 2.50 |
March 12, 2024 | 2.60 |
March 11, 2024 | 2.445 |
March 08, 2024 | 2.70 |
March 07, 2024 | 2.61 |
March 06, 2024 | 2.615 |
March 05, 2024 | 2.57 |
March 04, 2024 | 2.63 |
March 01, 2024 | 2.62 |
February 29, 2024 | 2.62 |
February 28, 2024 | 2.64 |
February 27, 2024 | 2.687 |
February 26, 2024 | 2.54 |
February 23, 2024 | 2.66 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
1.90
Minimum
Dec 16 2022
8.20
Maximum
May 11 2020
4.044
Average
3.448
Median
Total Return Level Benchmarks
Sanofi SA | 104.62 |
DBV Technologies SA | 0.6669 |
Cellectis SA | 2.99 |
PHAXIAM Therapeutics SA (DELISTED) | -- |
Genfit SA | 3.66 |